U.S. Dialysis Market Size by Type (Hemodialysis, Peritoneal Dialysis), Product & Service (Equipment {Dialysis Machines, Water Treatment Systems}, Consumables {Dialyzers, Catheters, Access Products, Concentrates}, Services {Acute Dialysis, Chronic Dialysis

U.S. Dialysis Market Size by Type (Hemodialysis, Peritoneal Dialysis), Product & Service (Equipment {Dialysis Machines, Water Treatment Systems}, Consumables {Dialyzers, Catheters, Access Products, Concentrates}, Services {Acute Dialysis, Chronic Dialysis) and End-use (In-center Dialysis, Home Dialysis), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028



The U.S. dialysis market is anticipated to showcase steady growth by 2028 owing to rising incidences of end-stage renal disease and diabetes across the globe. In addition, growing investment in research and development activities is likely to propel market growth through the review timeline.

During the COVID-19 pandemic, the industry witnessed a moderate impact as the coronavirus infection also affected the kidneys, prompting companies to carry out research & development activities in the field of dialysis. Moreover, favorable government initiatives have also supported U.S. dialysis market growth. For instance, in September 2020, the CMS (Centers for Medicare & Medicaid Services) finalized the ESRD treatment choices model that supports home dialysis and kidney transplants to maintain the quality of care and reduce Medicare expenditure for patients with chronic kidney illnesses.

Major players in the field of kidney dialysis have been focusing on various growth strategies, such as partnerships, collaborations, and rigorous R&D activities to enhance their standing in the U.S. dialysis market. For instance, in April 2022, Fresenius Medical Care, a German healthcare company, received approval from the U.S. Food and Drug Administration (FDA) for its VersiPD Cycler System. Fresenius markets the novel system as the quietest, smallest, and lightest, next-generation portable automated peritoneal dialysis system in the United States. VersiPD has been developed to improve health equity by making home therapy a more feasible option for patients suffering from kidney failure.

The U.S. dialysis market has been bifurcated based on end-use, type, product & services, and region. In terms of type, the market has been divided into peritoneal dialysis and hemodialysis. The peritoneal dialysis segment held more than 11% market share in 2021 due to rising preference for peritoneal dialysis as it requires a low level of assistance.

With respect to products & services, the market has been segregated into services, equipment, and consumables. The equipment segment garnered a valuation of more than $2 billion in 2021 as a result of the surging demand for continuous renal replacement therapy (CRRT).

On the basis of end-use, the industry has been categorized into two broad sectors, home dialysis and in-center dialysis. The home dialysis sector is slated to grow at a CAGR of over 7% through the analysis timespan as it allows patients to dialyze more frequently as well as avail cost-effective procedures at home.

On the regional spectrum, the U.S. dialysis market spans the regions of West South Central, East North Central, South Atlantic, East South Central, Pacific Central, North East, West North Central, and Mountain States. The Pacific Central dialysis market contributed to around 16% of the overall market revenue in 2021 attributed to mounting incidences of diabetes and hypertension in the region.